Order Article Reprints

Tripiciano C, Romani L, Mercadante S, Cursi L, Di Giuseppe M, Calo Carducci FI, Fragasso T, Di Chiara L, Garisto C, Sisto A, et al. The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit. Antibiotics. 2023; 12(5):796. https://doi.org/10.3390/antibiotics12050796

Tripiciano, Costanza, Lorenza Romani, Stefania Mercadante, Laura Cursi, Martina Di Giuseppe, Francesca Ippolita Calo Carducci, Tiziana Fragasso, Luca Di Chiara, Cristiana Garisto, Annamaria Sisto, and et al. 2023. "The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit" Antibiotics 12, no. 5: 796. https://doi.org/10.3390/antibiotics12050796

Tripiciano, C., Romani, L., Mercadante, S., Cursi, L., Di Giuseppe, M., Calo Carducci, F. I., Fragasso, T., Di Chiara, L., Garisto, C., Sisto, A., Vallesi, L., Costabile, V., Lancella, L., Bernaschi, P., & De Luca, M. (2023). The Prevalence of Carbapenemase-Producing Microorganisms and Use of Novel Cephalosporins for the Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria in a Pediatric Cardiac Intensive Care Unit. Antibiotics, 12(5), 796. https://doi.org/10.3390/antibiotics12050796